Skip to main content

Table 4 Treatment response

From: Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

Local response

6 weeks post completion of treatment [pts, (%)], N = 14

4-5 months post completion of treatment [pts, (%)], N = 14

at time of analysis [pts, (%)] N = 14

CR

4 (28.6%)

8 (57.1%)

13 (92.9%)

PR

8 (57.1%)

5 (35.7%)

0

SD

2 (14.3%)

1 (7.1%)

1(7.1%)

PD (locoregional)

0

0

0

PD (distant metastases)

0

1 (7.1%)

3 (21.4%)